Teva to Present at the Citi 2016 Global Healthcare Conference

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Citi 2016 Global Healthcare Conference.

Erez Vigodman will present on Thursday, December 8, 2016 at 10:15 AM EST.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2015 were $19.7 billion. For more information, visit www.tevapharm.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161207005698/en/

Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix
United States
215-591-8912
or
Ran Meir
United States
215-591-3033
or
Tomer Amitai
Israel
972 (3) 926-7656
or
PR:
Iris Beck Codner
Israel
972 (3) 926-7246
or
Denise Bradley
United States
215-591-8974

Source: Teva Pharmaceutical Industries Ltd.

You May Also Be Interested In

• Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy 
• SwiftPro Opens Ashburn Office, Holds 4.96 Stars Across 1,033 Reviews
• Globe PR Wire (GlobePRWire.org) Gains Momentum as a Press Release Distribution Service to Watch in 2026